Skip to content

Peter Dines joins Mercia Fund Management

Technology investment specialist Mercia Fund Management has appointed healthcare investor Peter Dines as investment director, head of life sciences.

He will work alongside three other heads of sector and investment directors at Mercia and brings two decades of healthcare experience having founded and run a number of successful technology businesses in the field.

Notable successes during his career include turning around obstetrics equipment firm Surgicraft, a company that saw sales quadruple under his leadership. It was subsequently sold to ISIS Equity Partners.

Dines also founded spinal and orthopaedic medical technology business Surgi C Group and distribution platform Newtech Ortho, both of which were subsequently acquired by private equity.

He holds several directorships across a range of life sciences businesses, including pharmaceuticals firm Cisiv, ultrasound service provider Diagnostic World and Spring Active, a company that delivers self-management programmes for those suffering long-term back pain.

Mark Payton, managing director of Mercia Fund Management, said:

“Peter brings significant experience and specialist expertise to the growing team at Mercia. He is highly regarded for his track record in identifying opportunities and growing value rapidly through hands-on management in businesses in the medtech and life sciences sector.

“He joins the three other sector-specific investment directors who lead our investment activity in digital; electronics and hardware; and advanced materials, engineering and specialised manufacturing.

“His remit across the life sciences sector will focus specifically on medtech, contract services and diagnostics.”

And Dines said he was delighted to join the firm at a time when it was looking to expand.

He said:

“I believe the offering of Mercia fund structures combined with expert support to assist growth is a very attractive proposition to early-stage technology companies.

“I am very much looking forward to using my past experience to help create new high-growth businesses in the life sciences and healthcare sector.”